[Federal Register Volume 59, Number 19 (Friday, January 28, 1994)]
[Unknown Section]
[Page ]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-1885]


[Federal Register: January 28, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 74

[Docket No. 91C-0432]


Listing of Color Additives for Coloring Sutures; D&C Violet No. 
2; Confirmation of Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of December 16, 1993, for the final rule that amended 
the color additive regulations to provide for the safe use of D&C 
Violet No. 2 to color poliglecaprone 25 (-caprolactone/
glycolide copolymer) absorbable sutures for general surgery.

DATES: Effective date confirmed: December 16, 1993.

FOR FURTHER INFORMATION CONTACT: Mitchell A. Cheeseman, Center for Food 
Safety and Applied Nutrition (HFS-216), Food and Drug Administration, 
200 C St. SW., Washington, DC 20204, 202-254-9511.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 15, 1993 
(58 FR 60106), FDA amended 21 CFR 74.3602 to provide for the safe use 
of D&C Violet No. 2 to color poliglecaprone 25 (-caprolactone/
glycolide copolymer) absorbable sutures for general surgery.
    FDA gave interested persons until December 16, 1993, to file 
objections or requests for a hearing. The agency received no objections 
or requests for a hearing on the final rule. Therefore, FDA finds that 
the final rule published in the Federal Register of November 15, 1993, 
should be confirmed.

List of Subjects in 21 CFR Part 74

    Color additives, Cosmetics, Drugs.
    Therefore, under the Federal Food, Drug, and Cosmetic Act (secs. 
201, 401, 402, 403, 409, 501, 502, 505, 601, 602, 701, 721 (21 U.S.C. 
321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e)) and under 
authority delegated to the Commissioner of Food and Drugs (21 CFR 
5.10), notice is given that no objections or requests for a hearing 
were filed in response to the November 15, 1993, final rule. 
Accordingly, the amendments promulgated thereby became effective 
December 16, 1993.

    Dated: January 24, 1994.
Michael R. Taylor,
Deputy Commissioner for Policy.
[FR Doc. 94-1885 Filed 1-27-94; 8:45 am]
BILLING CODE 4160-01-F